Publicaciones en colaboración con investigadores/as de Universitat de Vic (22)

2024

  1. Hypotension prediction index guided goal-directed therapy to reduce postoperative acute kidney injury during major abdominal surgery: study protocol for a multicenter randomized controlled clinical trial

    Trials, Vol. 25, Núm. 1

  2. Ibrutinib followed by ofatumumab consolidation in previously untreated patients with chronic lymphocytic leukemia (CLL): GELLC-7 trial from the Spanish group of CLL (GELLC)

    eClinicalMedicine, Vol. 73

  3. Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry

    Alimentary Pharmacology and Therapeutics, Vol. 60, Núm. 5, pp. 604-612

  4. Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA

    Clinical Gastroenterology and Hepatology, Vol. 22, Núm. 11, pp. 2280-2290

2023

  1. Empirical rescue treatment of Helicobacter pylori infection in third and subsequent lines: 8-year experience in 2144 patients from the European Registry on H. pylori management (Hp-EuReg)

    Gut, Vol. 72, Núm. 6, pp. 1054-1072

  2. Expanding the phenotypic spectrum of TRAPPC11-related muscular dystrophy: 25 Roma individuals carrying a founder variant

    Journal of medical genetics, Vol. 60, Núm. 10, pp. 965-973

  3. Helicobacter pylori Diagnostic Tests Used in Europe: Results of over 34,000 Patients from the European Registry on Helicobacter pylori Management

    Journal of Clinical Medicine, Vol. 12, Núm. 13

  4. Predictive capacity of a genetic risk score for coronary artery disease in assessing recurrences and cardiovascular mortality among patients with myocardial infarction

    Frontiers in Cardiovascular Medicine, Vol. 10

  5. QT interval and short-term outcome in acute heart failure

    Clinical Research in Cardiology, Vol. 112, Núm. 12, pp. 1754-1765

2022

  1. Effectiveness and Safety of High-Dose Dual Therapy: Results of the European Registry on the Management of Helicobacter pylori Infection (Hp-EuReg)

    Journal of Clinical Medicine, Vol. 11, Núm. 12

2021

  1. Adverse Event Profile During the Treatment of Helicobacter pylori: A Real-World Experience of 22,000 Patients From the European Registry on H. pylori Management (Hp-EuReg)

    The American journal of gastroenterology, Vol. 116, Núm. 6, pp. 1220-1229

  2. Compound endoscopic morphological features for identifying non-pedunculated lesions ≥20 mm with intramucosal neoplasia

    Cancers, Vol. 13, Núm. 21

  3. European registry on helicobacter pylori management: Effectiveness of first and second-line treatment in Spain

    Antibiotics, Vol. 10, Núm. 1, pp. 1-15

  4. The role of statins on helicobacter pylori eradication: Results from the european registry on the management of h. pylori (hp-eureg)

    Antibiotics, Vol. 10, Núm. 8

2020

  1. Association of circulating microRNAs with coronary artery disease and usefulness for reclassification of healthy individuals: The REGICOR study

    Journal of Clinical Medicine, Vol. 9, Núm. 5

  2. Benefit of primary percutaneous coronary interventions in the elderly with ST segment elevation myocardial infarction

    Open Heart, Vol. 7, Núm. 2

  3. Bismuth quadruple regimen with tetracycline or doxycycline versus three-in-one single capsule as third-line rescue therapy for Helicobacter pylori infection: Spanish data of the European Helicobacter pylori Registry (Hp-EuReg)

    Helicobacter, Vol. 25, Núm. 5

  4. Derivation and validation of SIDIAP-FHP score: A new risk model predicting cardiovascular disease in familial hypercholesterolemia phenotype

    Atherosclerosis, Vol. 292, pp. 42-51

2019

  1. Cross-sectional study of diet patterns in early and chronic schizophrenia

    Schizophrenia Research

2018

  1. Lesiones en la lucha tradicional: El caso de la lucha leonesa (2005-2015)

    Revista Internacional de Medicina y Ciencias de la Actividad Física y del Deporte, Vol. 18, Núm. 72, pp. 709-722